Evidence map›Paper›PMID 29854085›Full record

Trial reportOxidative medicine and cellular longevity2018

Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study.

Kyung-Hyun Cho, Suk-Jeong Kim, Dhananjay Yadav, Jae-Yong Kim, Jae-Ryong Kim

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Combination of Policosanol (RaydelPharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparison of the In Vivo Efficacy of Cuban (RaydelPharmaceuticals (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Combination Therapy of Cuban Policosanol (RaydelPharmaceuticals (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Cuban Policosanol (RaydelMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kyung-Hyun ChoDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.ORCID 0000-0003-1198-4140
Suk-Jeong KimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
Dhananjay YadavDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.ORCID 0000-0003-4047-7236
Jae-Yong KimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
Jae-Ryong KimDepartment of Biochemistry and Molecular Biology, Smart-Aging Convergence Research Center, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea.
Yeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Policosanol has been reported to improve blood pressure, lipid profile, and HDL functionality via inhibition of cholesteryl ester transfer protein (CETP) both

Indexed as

AdolescentAdultAgedAnticholesteremic AgentsBlood PressureDouble-Blind MethodFatty AlcoholsFemaleHumansHypertensionLipidsLipoproteins, HDLMiddle AgedPlacebo EffectTriglyceridesYoung AdultAnticholesteremic AgentsFatty AlcoholsHDL-triglycerideLipidsLipoproteins, HDLpolicosanolTriglycerides

Identifiers

PMID29854085
PMCPMC5944267
OpenAlexW2802673356

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.